Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

    Virtual Booth

    Contact Supplier

    Coral

    Virtual Booth

    Contact Supplier

    ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    Virtual Booth

    Contact Supplier

    Menu

    Ubrogepant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 32,516Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2AbbVie Corporation

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    AbbVie Corporation

    UBROGEPANT
    arrow
    Organic Process R&D
    Not Confirmed

    AbbVie Corporation

    Country
    arrow
    Organic Process R&D
    Not Confirmed

    Patent Expiration Date : 2031-11-10

    Date Granted : 2015-09-29

    UBROGEPANT

    Brand Name : UBRELVY

    Patent Number : 2817100

    Filing Date : 2011-11-10

    Strength per Unit : 50 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2031-11-10

    Date Granted : 2015-09-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AbbVie Corporation

    UBROGEPANT
    arrow
    Organic Process R&D
    Not Confirmed

    AbbVie Corporation

    Country
    arrow
    Organic Process R&D
    Not Confirmed

    Patent Expiration Date : 2031-11-10

    Date Granted : 2015-09-29

    UBROGEPANT

    Brand Name : UBRELVY

    Patent Number : 2817100

    Filing Date : 2011-11-10

    Strength per Unit : 100 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2031-11-10

    Date Granted : 2015-09-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF